Search research articles
Contact Us
Filters
Showing results (171-180 of 189) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry
R Ladenstein, T Philip, C Lasset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology
J Grill, M C Le Deley, D Gambarelli, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
December 27, 2005
[Childhood cancer incidence and survival rates in the Rhône-Alpes regional paediatric registry 1987-1999]
C Berger, B Trombert-Paviot, N Mitton, et al.
British Journal of Cancer
|
September 2, 2005
Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies
B Geoerger, G Vassal, F Doz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology
C Coze, O Hartmann, J Michon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study
F Pein, J Michon, D Valteau-Couanet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2005
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study
V Oyharcabal-Bourden, C Kalifa, J C Gentet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†
B Chauffert, L Feuvret, F Bonnetain, et al.
British Journal of Cancer
|
July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)
H Rubie, J Michon, D Plantaz, et al.
Revue Neurologique
|
May 3, 2011
[Medulloblastomas: review]
L Taillandier, M Blonski, C Carrie, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 189) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry
R Ladenstein, T Philip, C Lasset, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology
J Grill, M C Le Deley, D Gambarelli, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
December 27, 2005
[Childhood cancer incidence and survival rates in the Rhône-Alpes regional paediatric registry 1987-1999]
C Berger, B Trombert-Paviot, N Mitton, et al.
British Journal of Cancer
|
September 2, 2005
Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies
B Geoerger, G Vassal, F Doz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 1997
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology
C Coze, O Hartmann, J Michon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study
F Pein, J Michon, D Valteau-Couanet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2005
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study
V Oyharcabal-Bourden, C Kalifa, J C Gentet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†
B Chauffert, L Feuvret, F Bonnetain, et al.
British Journal of Cancer
|
July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)
H Rubie, J Michon, D Plantaz, et al.
Revue Neurologique
|
May 3, 2011
[Medulloblastomas: review]
L Taillandier, M Blonski, C Carrie, et al.
Page
of 19